Table 2.
Antimicrobial sensitivity patterns of S. Typhi and S. Paratyphi A, B and C isolates in Jiangsu Province, China, between 2013 and 2017.
| Antimicrobial agents |
S. Typhi (%) (N = 164) |
S. Paratyphi(%)A (N = 44) |
S. Paratyphi B (%) (N = 30) |
S. Paratyphi C (%) (N = 1) |
Aggregate (%) (N=239) |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| I | R | I | R | I | R | I | R | I | R | |
| Nalidixic acid | 3(1.8) | 94(57.3) | 1(2.3) | 25(56.8) | 2(6.8) | 9(30.0) | 0 | 0 | 6(2.5) | 128(53.6) |
| Ciprofloxacin | 58(35.4) | 4(2.4) | 5(11.4) | 6(13.6) | 2(6.8) | 1(3.3) | 1(100) | 0 | 66(27.6) | 11(4.6) |
| Ceftofur | 2(1.2) | 10(6.1) | 0 | 1(2.3) | 0 | 11(36.7) | 0 | 1(100) | 2(0.8) | 23(9.7) |
| Cefotaxime | 0 | 2(1.2) | 0 | 0 | 1(3.3) | 7(23.3) | 0 | 0 | 1(0.4) | 9(3.8) |
| Ceftazidime | 1(0.6) | 2(1.2) | 0 | 1(2.3) | 1(3.3) | 7(23.3) | 0 | 0 | 3(1.3) | 9(3.8) |
| Ceftriaxone | 1(0.6) | 3(1.8) | 0 | 0 | 0 | 7(23.3) | 0 | 0 | 1(0.4) | 10(4.2) |
| Ampicillin | 0 | 16(9.8) | 0 | 2(4.7) | 0 | 11(36.7) | 0 | 1(100) | 0 | 30(12.6) |
| Amoxicillin-clavulanic acid | 3(1.8) | 3(1.8) | 0 | 2(4.7) | 0 | 11(36.7) | 0 | 0 | 5(2.1) | 16(6.7) |
| Gentamicin | 1(0.6) | 2(1.2) | 0 | 0 | 1(3.3) | 5(16.7) | 0 | 0 | 2(0.8) | 7(2.9) |
| Tetracycline | 2(1.2) | 5(3.0) | 2(4.7) | 2(4.7) | 0 | 15(50.0) | 0 | 1(100) | 4(1.7) | 23(9.6) |
| Sulfamethoxazole | 0 | 2(1.2) | 2(4.7) | 1(2.3) | 0 | 12(40.0) | 0 | 1(100) | 2(0.8) | 16(6.7) |
R- Resistant, I- Intermediate.